Allisartan Isoproxil/Amlodipine Besylate

阿利沙坦酯/苯磺酸氨氯地平

Report date: 2026/03/30 17:02:26

Base Information

Drug NameAllisartan Isoproxil/Amlodipine Besylate
Drug Alias Name阿利沙坦酯氨氯地平SAL-0107SAL0107
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockers
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsEssential Hypertension
Approved Indications in ChinaEssential Hypertension
Original Approved Country/TerritoryMainland China
Original Approved Date2024/05/15
Country/TerritoryMainland China
CombinationsYes Allisartan IsoproxilAmlodipine Besylate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A